Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the effects of low-dose androgen on the motor and cognitive development of boys with Klinefelter syndrome.


Clinical Trial Description

Klinefelter syndrome (KS), a genetic disorder that affects males only, is characterized by having an extra X chromosome. The phenotype - or physical and learning features - includes testicular failure, tall stature, and specific cognitive and behavioral attributes such as diminished motor function, language-based learning difficulties, poor self-image, and shyness. The KS phenotype may be the result of androgen deficiency in utero, infancy, and childhood. For individuals with KS, androgen replacement is standard treatment in adolescence and adulthood but has not been used earlier in childhood or included in the standard medical care of KS children ages 4 to 12. The purpose of this study is to examine the effects of androgen on learning and development in boys with KS. Researchers also want to determine if low-dose androgen replacement at an early age will improve some of the learning difficulties associated with the disorder. The overall goal of this study is to address questions regarding the relationship of early androgen deficiency to learning and motor function. Participants in the study will be randomized to one of two treatment groups, receiving either oxandrolone (low-dose androgen) or placebo, for two years. All participants will be evaluated for safety at the beginning of the study and at 3, 6, 12, 18, and 24 months. Also at the beginning of the study and every 3 to 6 months thereafter (for a total of 6 visits), the researchers will perform a careful history and physical examination and a bone age X-ray, and obtain a blood sample. Participation in the trial will last two years and includes 6 clinic visits. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00348946
Study type Interventional
Source Thomas Jefferson University
Contact
Status Completed
Phase Phase 2
Start date July 2006
Completion date November 30, 2017

See also
  Status Clinical Trial Phase
Recruiting NCT03396562 - The eXtroardinarY Babies Study: Natural History of Health and Neurodevelopment in Infants and Young Children With Sex Chromosome Trisomy
Completed NCT02526628 - Thrombosis and Neurocognition in Klinefelter Syndrome
Completed NCT01678261 - X-chromosome Inactivation, Epigenetics and the Transcriptome N/A
Completed NCT01690013 - Life Quality and Health in Patients With Klinefelter Syndrome N/A
Completed NCT01918280 - Fertility Preservation in Cases of Klinefelter Syndrome. N/A
Completed NCT02787486 - Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
Completed NCT03325647 - TESTO: Testosterone Effects on Short-Term Outcomes in Infants With XXY Phase 4
Enrolling by invitation NCT03836300 - Parent and Infant Inter(X)Action Intervention (PIXI) N/A
Recruiting NCT05498090 - Interrogating Fatty Acid Metabolism Impairment and Clinical Correlates in Males With Klinefelter Syndrome Phase 4
Completed NCT00999310 - Neuropsychologic, Neuroradiologic, Endocrinologic, and Genetic Aspects of Klinefelter Syndrome N/A
Completed NCT02408445 - Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment Phase 4
Completed NCT00896272 - Adaptation Among Adolescents and Adults With Klinefelter Syndrome
Completed NCT02723305 - Cardiometabolic Profiles of Boys With Klinefelter Syndrome
Completed NCT05581147 - Thyroid Function and Structure IN Klinefelter Syndrome
Recruiting NCT05586802 - Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome Phase 3
Active, not recruiting NCT02430584 - Whole Blood Specimen Collection From Pregnant Subjects
Completed NCT01817296 - Klinefelter Fertility Preservation N/A
Completed NCT01585831 - Study of Psychological and Motor Effects of Testosterone in Adolescents With XXY/Klinefelter Syndrome N/A
Completed NCT01206270 - Androgen for Leydig Cell Proliferation Phase 2/Phase 3
Withdrawn NCT00347464 - Adaptive Behavior Assessment of Men With 49, XXXXY, Klinefelter Syndrome N/A